Biomerieux SA (BIMp)

Currency in EUR
124.75
-0.25(-0.20%)
Closed·
BIMp Scorecard
Full Analysis
Trading at a high earnings multiple
BIMp is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
124.75125.45
52 wk Range
95.60125.85
Key Statistics
Bid/Ask
93.35 / 102.30
Prev. Close
125
Open
125.45
Day's Range
124.75-125.45
52 wk Range
95.6-125.85
Volume
39
Average Volume (3m)
124
1-Year Change
30.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIMp Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Biomerieux SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Biomerieux SA Company Profile

bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VITEK 2, an automated identification and antimicrobial susceptibility testing system; API RANGE standardized ID strips; VITEK REVEAL Rapid AST system; ETEST gradient method on culture media; BIOMERIEUX EPISEQ CS whole genome sequencing solution for epidemiologic monitoring; and VIDAS, a specific marker of severe bacterial infections/sepsis. It also develops Biomérieux vision suite, a software that provides information to support diagnosis and clinical decision making; culture media and associated instruments; ARGENE that provides PCR tests for diagnosing viral respiratory diseases; EMAG system and NUCLISENS extraction reagents for DNA and RNA extraction; GENE-UP and VERIFLOW for detection of microorganisms for the food industry; ETEST for manual measurement of minimum inhibitory concentration; API and RAPIDEC CARBA NP for identification of bacteria and manual antimicrobial susceptibility testing; BIOBALL for quantitative microbiological quality control; CHEMUNEX, a microbiology instrument; ENDONEXT for detection of endotoxins; TEMPO for fluorescence counting of bacteria; and Hybiome, a CLIA technology, as well as lab consultancy service and training modules. It has partnership with Boehringer Ingelheim and Evotec. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Employees
14451
Market
France

Compare BIMp to Peers and Sector

Metrics to compare
BIMp
Peers
Sector
Relationship
P/E Ratio
34.0x12.0x−0.5x
PEG Ratio
1.690.100.00
Price/Book
3.5x2.6x2.6x
Price / LTM Sales
3.7x2.9x3.2x
Upside (Analyst Target)
-21.4%42.0%
Fair Value Upside
Unlock−2.7%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.67%
Dividend Yield
-
Industry Median 1.97%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 17, 2025
EPS / Forecast
1.82 / --
Revenue / Forecast
1.10B / --
EPS Revisions
Last 90 days

BIMp Income Statement

People Also Watch

258.30
ESLX
-1.86%
29.17
DAST
-1.72%
30.24
VIE
-1.05%
85.52
SASY
-0.38%
124.90
SGEF
-0.20%

FAQ

What Stock Exchange Does Biomerieux SA Trade On?

Biomerieux SA is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Biomerieux SA?

The stock symbol for Biomerieux SA is "BIMp."

What Is the Biomerieux SA Market Cap?

As of today, Biomerieux SA market cap is 14.71B.

What Is Biomerieux SA's Earnings Per Share (TTM)?

The Biomerieux SA EPS (TTM) is 3.67.

When Is the Next Biomerieux SA Earnings Date?

Biomerieux SA will release its next earnings report on 03 Sept 2025.

From a Technical Analysis Perspective, Is BIMp a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Biomerieux SA Stock Split?

Biomerieux SA has split 1 times.

How Many Employees Does Biomerieux SA Have?

Biomerieux SA has 14451 employees.

What is the current trading status of Biomerieux SA (BIMp)?

As of 30 Jul 2025, Biomerieux SA (BIMp) is trading at a price of 124.75, with a previous close of 125.00. The stock has fluctuated within a day range of 124.75 to 125.45, while its 52-week range spans from 95.60 to 125.85.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.